Share on LinkedInShare on LinkedIn

ARTICLE · 19 MAY 2020

COVID-19: Cross Country Update (May 12, 2020)

Miller Thomson
Miller Thomson
Contributor

Miller Thomson

Miller Thomson LLP ("Miller Thomson") is a national business law firm with approximately 500...

View firm profile
Explore more from Miller Thomson

The National Research Council of Canada (NRC) today announced two collaborations.

CanadaCoronavirus (COVID-19)

Federal

The Government of Canada announced the following measures:

NRC Vaccine Collaborations

The National Research Council of Canada (NRC) today announced two collaborations. The first is with CanSino Biologics Inc. (CanSinoBIO) to advance bioprocessing and clinical development in Canada of a candidate vaccine against COVID-19. CanSinoBIO's vaccine candidate received Chinese regulatory approval earlier this year to move ahead with human clinical trials in China. CanSinoBIO is in the process of filing a Clinical Trial Application with Health Canada.

The second collaboration is with the University of Saskatchewan's Vaccine and Infectious Disease Organization-International Vaccine Centre (USask's VIDO-InterVac) to accelerate the development and production of a candidate COVID-19 antigen in mammalian cells.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from